Trinity biotech announces it has begun shipments of its new hiv screening test, trinscreen hiv to kenya

Dublin, ireland, dec. 27, 2023 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to kenya of its new rapid hiv screening test, trinscreen hiv.
TRIB Ratings Summary
TRIB Quant Ranking